TIVC - Tivic Health Systems, Inc.
Pre-Market:
Chart Events
Hammer
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 0.0980 |
| Open | 0.1000 |
| Bid | 0.0000 x 1100 |
| Ask | 0.0000 x 1200 |
| Day's Range | 0.0932 - 0.1000 |
| 52 Week Range | 0.0900 - 2.8700 |
| Volume | |
| Avg. Volume | 2,803,285 |
| Market Cap | 2.852M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.8800 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.10 |
Fair Value
Related Research
ZacksTivic Health Systems, Inc. (TIVC) Reports Q1 Loss, Lags Revenue Estimates
Tivic Health Systems, Inc. (TIVC) delivered earnings and revenue surprises of 0% and 27.69%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireTivic Reports First Quarter 2023 Financial Results
SAN FRANCISCO, May 15, 2023--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, is pleased to announce its financial results for the first quarter of 2023 ended March 31, 2023 ("Q1 2023").
Business WireTivic Health To Report First Quarter 2023 Financial Results on May 15th Via Conference Call and Webcast
SAN FRANCISCO, May 11, 2023--Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the first quarter 2023 via a pre-recorded conference call and webcast on Monday, May 15th, 2023 at 1:30 pm PT / 4:30 pm ET.
ZacksAzenta (AZTA) Reports Q2 Loss, Misses Revenue Estimates
Brooks (AZTA) delivered earnings and revenue surprises of -20% and 8.20%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireTivic Health Launches B2B Portal, Accelerates Healthcare Commercial Sales Expansion
SAN FRANCISCO, May 08, 2023--Tivic Health Launches B2B Portal, Accelerates Healthcare Commercial Sales Expansion
Business WireTivic Announces Appointment of New Interim CFO, Kimberly Bambach, and Strategic Advisor to the Board, Christina Valauri
SAN FRANCISCO, May 03, 2023--Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the appointment of veteran Kimberly Bambach to serve as Interim Chief Financial Officer of the company and the engagement of Christina Valauri as a strategic advisor to the Board of Directors. These additions aim to strengthen the company's financial foundation and bring growth and M&A expertise to the team.
Business WireTivic Health Expands Clinical Study of Post-Operative Pain in Nasal and Sinus Surgeries
SAN FRANCISCO, April 19, 2023--Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that it has expanded its post-operative pain clinical study to include Otolaryngology and Facial Plastic Surgery patients. This study aims to investigate the potential benefits of a drug-free alternative to traditional post-operative pain management methods.
Business WireTivic, The Feinstein Institutes for Medical Research Announce Pilot Study to Test Novel Non-Invasive Bioelectronic Approach to Vagus Nerve Stimulation
SAN FRANCISCO & MANHASSET, N.Y., April 13, 2023--Tivic Health® Systems, Inc. ("Tivic") (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced a research collaboration with The Feinstein Institutes for Medical Research to conduct a pilot clinical study that will test a novel non-invasive bioelectronic device approach for vagus nerve stimulation.
Business WireTivic Expands Bioelectronic Portfolio; Files Patent Application for New Approach to Non-Invasive Vagus Nerve Stimulation
SAN FRANCISCO, April 11, 2023--Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it has filed its first patent in Vagus Nerve Stimulation with the U.S. Patent Office (USPTO), expanding its intellectual property portfolio into new clinical targets.
Business WireTivic Health Reports Fiscal Year 2022 Financial Results
SAN FRANCISCO, March 31, 2023--Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced its financial results for the year ending December 31, 2022.
- News Direct
CapitalGainsReport: Stocks Under $2 Making Headlines (GROM, LOCL, TIVC, NKLA)
As an investor, staying up-to-date on the latest news and developments in the stock market is crucial for making informed decisions. In today's article, we’re taking a look at four stocks with good...
Business WireTivic Health Systems, Inc. Cuts Component Manufacturing Costs by 70%, Completes Second Key Supplier Qualification
SAN FRANCISCO, March 29, 2023--Tivic Health® Systems, Inc. ("Tivic") (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced it has completed the supplier qualification and first article inspection of Microart Services, Inc., one of two new partners announced in Q4 of 2022.
Business WireTivic Health Systems, Inc. to Report Fiscal Year 2022 Financial Results on March 31st Via Conference Call and Webcast
SAN FRANCISCO, March 24, 2023--Tivic Health® Systems, Inc. ("Tivic Health", Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that it will report financial results for the year ended December 31, 2022, via pre-recorded conference call and webcast on Friday, March 31, 2023, at 1:30 pm PT / 4:30 pm ET.
Business WireTivic Cuts Final Assembly Production Costs by 40%, Completes First Key Supplier Qualification
SAN FRANCISCO, March 14, 2023--Tivic Health® Systems, Inc. ("Tivic") (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced it has completed the supplier qualification and first article inspection of ALOM, one of two new partners announced in Q4 of 2022.
Business WireTivic Named to Fast Company’s Annual List of the World’s Most Innovative Companies 2023 In the Medical Device Category
SAN FRANCISCO, March 02, 2023--Tivic Health® Systems, Inc. ("Tivic") (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023 in the Medical Device category. Tivic’s first commercial product, ClearUP, is an FDA approved and CE-Marked bioelectronic sinus device and the first of its kind to reduce symptoms of inflammation such as si
Business WireTivic Announces Successful Recertification of ISO 13485 Quality Management System and the European Medical Device CE-Mark
SAN FRANCISCO, February 23, 2023--Tivic Health® Systems, Inc. ("Tivic") (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced it has received recertification of ISO 13485, the international standard for medical device quality systems. The company also announced the recertification of ClearUP under the European Union Medical Device Certificate (CE-Mark).
Business WireTivic Health Systems, Inc. Announces Closing of Public Offering
SAN FRANCISCO, February 13, 2023--Tivic Health® Systems, Inc. ("Tivic") (Nasdaq: TIVC) ("Tivic" or the "Company), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced the closing of its previously announced underwritten public offering of an aggregate of 20,000,000 shares of common stock at a public offering price of $0.25 per share, for aggregate gross proceeds of approximately $5,000,000, before deducting underwriting discounts a
Business WireTivic Health Systems, Inc. Announces Pricing of Public Offering
SAN FRANCISCO, February 09, 2023--Tivic Health® Systems, Inc. ("Tivic") (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced the pricing of an underwritten public offering of an aggregate of 20,000,000 shares of common stock. Each share is being sold to the public at a price of $0.25 per share, for aggregate gross proceeds of approximately $5,000,000, before deducting underwriting discounts and offering expenses. In
Business WireTivic Health Named Most Pioneering Bioelectronic Medicine Company by Global Health & Pharma Magazine
SAN FRANCISCO, January 24, 2023--Tivic Health® Systems, Inc. ("Tivic") (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that Global Health & Pharma (GHP) has named Tivic Health the Most Pioneering Bioelectronic Medicine Company of 2022.
ZacksHere's Why Tivic Health Systems, Inc. (TIVC) Looks Ripe for Bottom Fishing
Tivic Health Systems, Inc. (TIVC) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Business WireTivic Health and Reliefband Technologies, LLC Terminate Acquisition Agreement
SAN FRANCISCO, December 09, 2022--Tivic Health® Systems, Inc. ("Tivic") (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that Tivic Health and Reliefband Technologies, LLC have, by mutual agreement, terminated the parties’ agreement for the acquisition of the Reliefband product line and related assets entered into on October 7, 2022. Information regarding the termination is contained in the company’s Current Rep
- GlobeNewswire
UPDATE: Diamond Equity Research Releases Update Note on Tivic Health Systems, Inc. (NASDAQ: TIVC)
NEW YORK, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released update note on Tivic Health Systems, Inc. (NASDAQ: TIVC). The update note includes information on the Tivic Health Systems’ financial results, management commentary, recent developments, outlook, risks, and our revised valuation estimates. The update note is available here. Highlights from the note include: Q3 2022 Key Financial Hi
Business WireTivic Health Signs Agreement with ALOM to Manage Product Supply Chain, Assembly, and Logistics
SAN FRANCISCO, December 01, 2022--Tivic Health® Systems, Inc. ("Tivic") (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced it has hired ALOM Technologies Corporation ("ALOM"), a leader in global supply chain product and service delivery programs, to manage product supply chain, assembly, and logistics.
- GlobeNewswire
Diamond Equity Research Releases Update Note on Tivic Health Systems, Inc. (NASDAQ: TIVC)
NEW YORK, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released update note on Tivic Health Systems, Inc. (NASDAQ: TIVC). The update note includes information on the Tivic Health Systems’ financial results, management commentary, recent developments, outlook, risks, and our revised valuation estimates. The update note is available here. Highlights from the note include: Q3 2022 Key Financial Hi
Simply Wall St.Tivic Health Systems Third Quarter 2022 Earnings: US$0.27 loss per share (vs US$0.90 loss in 3Q 2021)
Tivic Health Systems ( NASDAQ:TIVC ) Third Quarter 2022 Results Key Financial Results Revenue: US$477.0k (up 89% from...